Apollon Wealth Management LLC Buys 7,899 Shares of Agilent Technologies, Inc. (NYSE:A)

Apollon Wealth Management LLC raised its stake in Agilent Technologies, Inc. (NYSE:A) by 419.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,784 shares of the medical research company’s stock after purchasing an additional 7,899 shares during the period. Apollon Wealth Management LLC’s holdings in Agilent Technologies were worth $1,314,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of A. CKW Financial Group boosted its stake in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. boosted its position in shares of Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies during the 3rd quarter valued at about $28,000. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies in the third quarter valued at about $31,000. Finally, Fortitude Family Office LLC raised its position in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after purchasing an additional 95 shares in the last quarter.

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Wall Street Analysts Forecast Growth

A has been the topic of a number of recent research reports. Citigroup lifted their price objective on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $135.00 to $145.00 in a research note on Monday. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $144.38.

Agilent Technologies Stock Down 1.0 %

Shares of NYSE:A opened at $143.69 on Tuesday. The company has a 50 day moving average of $141.59 and a 200-day moving average of $139.37. Agilent Technologies, Inc. has a one year low of $124.16 and a one year high of $155.35. The stock has a market cap of $40.99 billion, a price-to-earnings ratio of 32.51, a P/E/G ratio of 4.00 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 25th. The medical research company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company posted $1.38 EPS. The business’s revenue for the quarter was up .8% compared to the same quarter last year. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st were issued a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a yield of 0.69%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.